| Name: | NABRIVA THERAPEUTICS US Inc. |
| Jurisdiction: | Kentucky |
| Profit or Non-Profit: | Profit |
| Legal type: | Foreign Corporation |
| Status: | Active |
| Standing: | Good |
| File Date: | 17 Sep 2019 (5 years ago) |
| Organization Date: | 22 Aug 2014 (10 years ago) |
| Authority Date: | 17 Sep 2019 (5 years ago) |
| Last Annual Report: | 02 Aug 2024 (6 months ago) |
| Organization Number: | 1071617 |
| Industry: | Chemicals and Allied Products |
| Number of Employees: | Small (0-19) |
| Principal Office: | 414 COMMERCE DRIVE, SUITE 120, FORT WASHINGTON, PA 19034 |
| Place of Formation: | DELAWARE |
| Name | Role |
|---|---|
| Dave Maggio | Secretary |
| Name | Role |
|---|---|
| CT CORPORATION SYSTEM | Registered Agent |
| Name | Role |
|---|---|
| Dave Maggio | Treasurer |
| Name | Role |
|---|---|
| Michael Hogan | President |
| Name | Role |
|---|---|
| Ted Schroeder | Director |
| Name | Role |
|---|---|
| ZER YANG | Authorized Rep |
| Name | Role |
|---|---|
| ZER YANG | Accountant |
| Name | Role |
|---|---|
| GARY SENDER | CFO |
| Name | File Date |
|---|---|
| Annual Report | 2024-08-02 |
| Annual Report | 2023-04-11 |
| Principal Office Address Change | 2022-05-05 |
| Annual Report | 2022-05-05 |
| Annual Report | 2021-06-08 |
| Annual Report | 2020-06-09 |
Date of last update: 25 Nov 2024
Sources: Kentucky Secretary of State
